Matinas BioPharma Holdings (MTNB) Dividends Paid - Common (2017 - 2018)
Matinas BioPharma Holdings (MTNB) posted quarterly Dividends Paid - Common of $587000.0 for Q3 2018, up 29450.0% quarter-over-quarter from -$2000.0 in Q2 2018.
Matinas BioPharma Holdings (MTNB) Dividends Paid - Common (2017 - 2018) Analysis & Trends
Matinas BioPharma Holdings (MTNB) has reported Dividends Paid - Common for 2 consecutive years, with $587000.0 the latest figure, recorded in Q3 2018.
- In Q3 2018, Dividends Paid - Common changed N/A year-over-year to $587000.0; the TTM figure through Sep 2018 stood at $1.1 million (changed N/A YoY), while the FY2017 annual figure was $601000.0, changed N/A from the prior year.
- Dividends Paid - Common improved to $587000.0 in Q3 2018 per MTNB's latest filing, from -$2000.0 in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $589000.0 in Q1 2018 and bottomed at -$108000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 96.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 34.60 Mn |
| 10 | Matinas BioPharma Holdings | 1.25 Mn | 437,566.66 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 587,000.00 |
| Sep 30, 2018 | 587,000.00 |
| Jun 30, 2018 | -2,000.00 |
| Jun 30, 2018 | -2,000.00 |
| Mar 31, 2018 | 589,000.00 |
| Mar 31, 2018 | 589,000.00 |
| Dec 31, 2017 | -108,000.00 |
| Dec 31, 2017 | -108,000.00 |